Pancreatic ductal adenocarcinoma (PDA) is a lethal disease for which remarkable
therapeutic resistance is the norm. Conventional immunotherapies, like immune checkpoint …

Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …

Oncogenesis and progression of pancreatic ductal adenocarcinoma (PDAC) are driven by
complex interactions between the neoplastic component and the tumor microenvironment …

The intricate interplay between the host and its microbiota has garnered increasing attention
in the past decade. Specifically, the emerging recognition of microorganisms within diverse …

Background: Pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDAC),
continues to pose a significant clinical and scientific challenge. The most significant finding …

In order to advance our understanding of precancers in the pancreas, 69 pancreatic
intraductal papillary neoplasms (IPNs), including 64 intraductal papillary mucinous …

Despite great efforts to improve understanding and treatment of pancreatic cancer, mainly
pancreatic ductal adenocarcinoma (PDAC), the outcome of this malignant disease today is …